Healthy Heart Africa Capacity Building Activities

Healthy Heart Africa capacity building activities

AstraZeneca
AstraZeneca’s Healthy Heart Africa programme includes a range of capacity building activities to help reduce the burden of hypertension in Kenya.
Continue reading

Possible partnership

Merck & Co
Merck & Co., Inc. partnered with non-government organisation (NGO) Possible to strengthen supply chains in Nepal.
Continue reading

Global Health Pharma Fund Minilab

Merck KGaA
Merck KGaA supports the Global Pharma Health Fund (GPHF) Minilab, a mobile medicine authenticator.
Continue reading

Tuberculosis-focused capacity building

Eli Lilly
Eli Lilly is undertaking a range of capacity building projects in India focused on tuberculosis.
Continue reading

Malaria-focused capacity building

Novartis
Novartis is undertaking several capacity building projects focused on malaria in sub-Saharan Africa.
Continue reading
SMS For Life

SMS for Life

Novartis
Novartis’ SMS for Life programme uses mobile technology to reduce medicine stock-outs in sub-Saharan Africa.
Continue reading
Tianjin University-AstraZeneca Joint Laboratory

Tianjin University-AstraZeneca Joint Laboratory

AstraZeneca
AstraZeneca partners with Tianjin University to improve manufacturing safety standards in China.
Continue reading
R&D Capacity Building Model

R&D capacity building model

GSK
GSK has a comprehensive model to build local R&D capacity in response to need.
Continue reading

Manufacturing capacity building approach

Merck KGaA
Merck KGaA takes a comprehensive approach to building manufacturing capacity in-house and with third parties.
Continue reading

M-Tiba mobile wallet

Pfizer
Pfizer has supported the development and implementation of M-Tiba, a mobile wallet for healthcare savings and payments.
Continue reading
Africa 2020 R&D Capacity Building

Africa 2020 R&D capacity building

GSK
GSK’s Africa 2020 strategy includes a range of R&D capacity building partnerships in sub-Saharan Africa.
Continue reading
Leprosy-focused Capacity Building

Leprosy-focused capacity building

Novartis
Novartis is undertaking a range of projects to build local capacity to address leprosy, mainly in south-east Asia.
Continue reading
Young Health Programme

Young Health Programme

AstraZeneca
AstraZeneca’s Young Health Programme is a philanthropic capacity building programme focused on preventing non-communicable diseases among adolescents.
Continue reading
Developing Country Vaccine Manufacturers Network Training Partnership

Developing Country Vaccine Manufacturers Network training partnership

Merck KGaA
Merck KGaA has a training partnership with the Developing Countries Vaccine Manufacturers Network (DCVMN).
Continue reading

StartHealth investment programme

Pfizer
Pfizer is supporting StartHealth, a health technology start-up investment programme.
Continue reading
Informed Push Model

Informed Push Model

Merck & Co
The Informed Push Model is a distribution project aiming to improve supply chains and stock management for contraceptives in Senegal.
Continue reading
MVacciNation

mVacciNation

GSK
GSK’s mVacciNation programme is a mobile technology-based supply chain management capacity building programme, aiming to increase childhood immunisation in Mozambique.
Continue reading

International Society of Pharmacovigilance Special Interest Group

Bayer
Bayer co-founded an International Society of Pharmacovigilance Special Interest Group to develop and share innovative risk minimisation methods and tools.
Continue reading

Approach to R&D capacity building

Novartis
Novartis takes a comprehensive approach to targeting local R&D capacity building needs.
Continue reading

African Association of Essential Drugs National Purchasing Centres training partnership

Sanofi
Sanofi has a training partnership with the African Association of Essential Drugs National Purchasing Centres (ACAME).
Continue reading